1. Home
  2. RWT vs SGP Comparison

RWT vs SGP Comparison

Compare RWT & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwood Trust Inc.

RWT

Redwood Trust Inc.

HOLD

Current Price

$5.11

Market Cap

648.6M

Sector

Real Estate

ML Signal

HOLD

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$21.16

Market Cap

650.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RWT
SGP
Founded
1994
2019
Country
United States
United States
Employees
351
65
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
648.6M
650.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RWT
SGP
Price
$5.11
$21.16
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$6.82
$45.00
AVG Volume (30 Days)
3.8M
169.0K
Earning Date
04-29-2026
05-15-2026
Dividend Yield
12.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$26.59
N/A
Revenue Next Year
$22.21
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.19
$17.06
52 Week High
$6.97
$30.56

Technical Indicators

Market Signals
Indicator
RWT
SGP
Relative Strength Index (RSI) 56.01 54.38
Support Level $5.11 $20.95
Resistance Level $5.40 $22.80
Average True Range (ATR) 0.20 1.93
MACD 0.06 0.17
Stochastic Oscillator 94.21 60.03

Price Performance

Historical Comparison
RWT
SGP

About RWT Redwood Trust Inc.

Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: